United Kingdom · Question · Written question
UIN 36853
Tixagevimab/cilgavimab
Introduced
14 July 2022
Last action
19 July 2022 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
19 July 2022
Summary
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 14 June 2022 to Question 15354 on Evusheld, whether his Department has received advice from clinicians on the most appropriate option for the use of Evusheld.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
14 July 2022
Written question
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 14 June 2022 to Question 15354 on Evusheld, whether his Department has received advice from clinicians on the most appropriate option for the use of Evusheld.
Source: Commons
19 July 2022
Answer
We are currently considering the advice received.
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2022-07-14/36853
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1489247
- uk · wq-1489247 · source updated 19 July 2022